Skip to main content

Published locations for Multiple sclerosis: Discontinuing fingolimod improves humoral response after SARS-CoV-2 vaccination

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Multiple sclerosis: Discontinuing fingolimod improves humoral response after SARS-CoV-2 vaccination

User login

  • Reset your password
  • /content/multiple-sclerosis-discontinuing-fingolimod-improves-humoral-response-after-sars-cov-2
  • /neurology/msresourcecenter/article/252955/multiple-sclerosis/multiple-sclerosis-discontinuing